MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170,152 | +78.5% | 26,863 | +48.1% | 0.00% | 0.0% |
| Q2 2023 | $655,398 | +7.4% | 18,140 | +10.6% | 0.00% | 0.0% |
| Q1 2023 | $609,976 | -11.6% | 16,406 | +7.7% | 0.00% | 0.0% |
| Q4 2022 | $689,891 | -46.2% | 15,226 | -17.0% | 0.00% | 0.0% |
| Q3 2022 | $1,282,000 | +0.5% | 18,354 | -3.4% | 0.00% | 0.0% |
| Q2 2022 | $1,276,000 | -10.1% | 19,008 | +10.1% | 0.00% | 0.0% |
| Q1 2022 | $1,419,000 | -88.5% | 17,262 | -80.2% | 0.00% | -90.0% |
| Q4 2021 | $12,340,000 | +277.6% | 87,165 | +330.3% | 0.01% | +233.3% |
| Q2 2021 | $3,268,000 | +8.0% | 20,257 | +14.6% | 0.00% | 0.0% |
| Q1 2021 | $3,027,000 | -20.0% | 17,673 | +2.5% | 0.00% | -25.0% |
| Q4 2020 | $3,786,000 | +760.5% | 17,239 | +187.3% | 0.00% | +300.0% |
| Q1 2019 | $440,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |